OOIR: Observatory of International Research

Papers

(The H4-Index of Microbial Cell Factories is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health	269
A critical review on various feedstocks as sustainable substrates for biosurfactants production: a way towards cleaner production	147
Rhamnolipid the Glycolipid Biosurfactant: Emerging trends and promising strategies in the field of biotechnology and biomedicine	146
Pediococcus pentosaceus, a future additive or probiotic candidate	105
Challenging microalgal vitamins for human health	104
Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation	99
Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota	98
Emerging prospects of macro- and microalgae as prebiotic	81
Maximizing PHB content in Synechocystis sp. PCC 6803: a new metabolic engineering strategy based on the regulator PirC	80
The history, state of the art and future prospects for oleaginous yeast research	76
Microbial production of ectoine and hydroxyectoine as high-value chemicals	70
Enhanced production of taxadiene in Saccharomyces cerevisiae	67
Multi-pathogen infections and Alzheimer’s disease	66
Microbial glycoconjugates in organic pollutant bioremediation: recent advances and applications	61
Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up	57
Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota	57
Engineered microbial consortia: strategies and applications	57
Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice	52
Debottlenecking the biological hydrogen production pathway of dark fermentation: insight into the impact of strain improvement	49
Advances in the human skin microbiota and its roles in cutaneous diseases	48
Impact of organic carbon acquisition on growth and functional biomolecule production in diatoms	46
Engineering the Calvin–Benson–Bassham cycle and hydrogen utilization pathway of Ralstonia eutropha for improved autotrophic growth and polyhydroxybutyrate production	45
Bioactive compounds and biomedical applications of endophytic fungi: a recent review	44
Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study	44
Engineering of a genome-reduced strain Bacillus amyloliquefaciens for enhancing surfactin production	43

The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors	43
Insights into the structure of Escherichia coli outer membrane as the target for engineering microbial cell factories	43
The generation of metabolic changes for the production of high-purity zeaxanthin mediated by CRISPR-Cas9 in Chlamydomonas reinhardtii	42
Metabolic engineering of Rhodococcus jostii RHA1 for production of pyridine-dicarboxylic acids from lignin	41
Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway	40
Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis	40
The role of the gut microbiota on the metabolic status of obese children	37
Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota	36
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment	36
Machine learning for data integration in human gut microbiome	35
Dual regulation of lipid droplet-triacylglycerol metabolism and ERG9 expression for improved β-carotene production in Saccharomyces cerevisiae	35
Compartmentalization and transporter engineering strategies for terpenoid synthesis	35
Engineered probiotics	35
Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age	35
Purification and identification of a surfactin biosurfactant and engine oil degradation by Bacillus velezensis KLP2016	35